GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Tariff Resilience Score

uniQure NV (FRA:UQ1) Tariff Resilience Score : 6/10 (As of Jul. 10, 2025)


View and export this data going back to 2014. Start your Free Trial

What is uniQure NV Tariff Resilience Score?

uniQure NV has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

uniQure NV has Biotech firm with manufacturing in Europe and sales in the US. Moderate exposure to tariffs on medical imports. Historical tariffs have had limited impact due to niche market. Mitigation through strategic partnerships and potential pricing power.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes uniQure NV might have Average Resilient.

Competitive Comparison of uniQure NV's Tariff Resilience Score

For the Biotechnology subindustry, uniQure NV's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

uniQure NV's Tariff Resilience Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, uniQure NV's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where uniQure NV's Tariff Resilience Score falls into.


;
;

uniQure NV  (FRA:UQ1) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

uniQure NV Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of uniQure NV's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

uniQure NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Tariff Resilience Score
Comparable Companies
IMNM XERS GHRS SNDX AVBP REPL MENS VIR COGT AVXL VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
QURE:USA 0EE0:UK UQ1:Germany
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
Website
https://www.uniqure.com
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV Headlines

No Headlines